In an expansion of its previous moves to cut insulin prices, Sanofi will cap the price of each of its insulin products at $35 per month in the U.S. regardless of a patient's insurance status. The move ...

A nonprofit in Cambridge, Massachusetts is aiming to make insulin more accessible for diabetes patients in the United States by selling vials of the drug at a fraction of the cost. According to WBZ-TV ...

The U.S. Food & Drug Administration has issued an urgent medical device correction. Specifically, an error on the t:slim X2 insulin pump has been stopping insulin ...

A medical device manufacturer has issued an urgent correction for select insulin pumps due to a possible error that could result in insulin not being delivered, the U ...

Insulin is rising in cost despite its necessity for survival for people with diabetes. Patent evergreening by insulin manufacturers hinders competition and keeps prices high. Congress should pass ...

Please provide your email address to receive an email when new articles are posted on . Technsophere insulin conferred a similar HbA1c as a rapid-acting analog for children and adolescents with ...

Craig Beall currently receives funding from Diabetes UK, Breakthrough T1D, Steve Morgan Foundation Type 1 Diabetes Grand Challenge, Medical Research Council, NC3Rs, Society for Endocrinology and ...

Artificial intelligence (AI) can enhance insulin dosing accuracy for hospitalized patients with type 2 diabetes (T2D), improving glycemic control and streamlining physician workflows. Between 2018 and ...

Just like Taylor Swift during her Eras Tour, it seems like weight loss supplements are everywhere right now—and that includes insulin resistance supps. So, are insulin resistance supplements legit—and ...

Adrenomedullin disrupts insulin signaling in blood vessels, leading to systemic insulin resistance in obesity-associated type 2 diabetes, according to a new study by a team at the Max Planck Institute ...